Navigation Links
Nurse Turned Filmmaker Makes Lifesaving Film
Date:7/23/2009

TAMPA, Fla., July 23 /PRNewswire/ -- Bay Area Registered nurse-turned filmmaker, David Burton, dropped the stethoscope, scrubs and chemical drugs and armed himself with a movie to help save lives. After seeing so many deaths due to preventable illness, Burton found an alarming connection between America's food ingredients (specifically hydrogenated oil) and the leading causes of death. Now he's going to tell the world what he found. The movie titled "inGREEDients" is already causing quite a stir with the Tampa Bay residents.

Russell Hess, another Bay Area filmmaker, decided to help Burton on his quest after having a battle with his own heart. "I was having typical symptoms of early heart disease and thought how could this be happening? I exercise, eat right and get enough rest. . .what's up?" Tests on Hess' "health" showed elevated cholesterol and triglycerides. After seeing "inGREEDients" he started seeking a cure and stopped treating symptoms.

Hess went on to say, "Whatever you think you know about diet and exercise is wrong. . .dead wrong." Hess has recently helped many filmmakers distribute their narrative films, mostly genre pieces, horror and Sci-Fi films. This is Hess' first attempt at a documentary. "It's the scariest movie I've ever seen and it's NOT a horror movie."

"InGREEDients" makes the connection between some of the nastiest and believe it or not, preventable diseases that are now at epidemic levels.

Burton said, "There's probably a reason the experts won't state for a fact why Michael Jackson and Billy Mays met their demise, and we may never know. The point of my movie is not necessarily to frighten people, but to simply get them to make better choices."

If you see one movie this year that could save your life, "inGREEDients" is that movie!

A public screening is scheduled on July 24th at 7PM at the Art In
'/>"/>

SOURCE Sir Rebel Films
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. 125,000 Solutions to the Primary Care Shortage - Nurse Practitioners (NPs)
2. Nurses Working More in Down Economy
3. Tenet Nurses, Healthcare Workers Take Action to Protest Sick Leave Cuts
4. Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award
5. ANA Nurses Stand With Obama in Calling for Healthcare Reform Now
6. United American Nurses Hails House Health Care Reform Bill
7. Demand for Short-Term Medical Help Leads to Growth for Travel Nursing Staffing Agency; Prompts Move to New Location and Addition of New Online Tools for Nurses
8. Nurses File Cal-OSHA Complaint After Hospital Refuses to Supply Swine Flu Masks for Units with Infected Patients
9. Joint Committee on Judiciary Holds July 14 Hearing On Bill to Increase Criminal Penalties for Assaulting Nurses
10. PR Whiz Belinda Foster Launches Michael Jacksons Nurse, Cherilyn Lee, on World Media Campaign
11. Travel Nurse Across America Expands Into New Offices
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 1NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 1The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 3The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 4Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2
Other Medicine Technology:New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 2SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 3SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 4SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 5SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 6SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients 7